Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-04
1992-05-12
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514824, 514529, 514559, 514574, 560119, 549292, A61K 3135, C07D30930
Patent
active
051128578
ABSTRACT:
This invention relates to compounds of formulae I and II ##STR1## which are metabolites of tetrahydrosimvastatin and 5-hydroxy-tetrahydrosimvastatin and which are HMG-CoA reductase inhibitors.
REFERENCES:
patent: 4517373 (1985-05-01), Terahara et al.
patent: 4537859 (1985-08-01), Terahara et al.
patent: 4584389 (1986-04-01), Slitzinger et al.
patent: 4604472 (1986-08-01), Ide et al.
patent: 4733003 (1988-03-01), Ide et al.
patent: 4833258 (1989-05-01), Smith et al.
patent: 4897402 (1990-01-01), Duggan et al.
patent: 4921974 (1990-05-01), Duggan
patent: 4940727 (1990-07-01), Inamine et al.
patent: 4963538 (1990-10-01), Duggan et al.
Terahara et al., "MB-530B derivatives and their pharmaceutical compositions" CA 99:70288t (1983).
DiPrima Joseph F.
Ivy C. Warren
Merck & Co. , Inc.
Owens Amelia A.
Winokur Melvin
LandOfFree
HMG-CoA reductase inhibitor metabolites does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HMG-CoA reductase inhibitor metabolites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HMG-CoA reductase inhibitor metabolites will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426230